Global Antimalarial Medication Market Research Report 2023

Report ID: 1975276 | Published Date: Oct 2024 | No. of Page: 89 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Antimalarial Medication Market Overview
    1.1 Product Overview and Scope of Antimalarial Medication
    1.2 Antimalarial Medication Segment by Type
        1.2.1 Global Antimalarial Medication Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Plasmodium Falciparum
        1.2.3 Plasmodium Malariae
        1.2.4 Plasmodium Vivax
        1.2.5 Plasmodium Ovale
    1.3 Antimalarial Medication Segment by Application
        1.3.1 Global Antimalarial Medication Sales Comparison by Application: (2022-2028)
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 E- Commerce
        1.3.5 Others
    1.4 Global Antimalarial Medication Market Size Estimates and Forecasts
        1.4.1 Global Antimalarial Medication Revenue 2017-2028
        1.4.2 Global Antimalarial Medication Sales 2017-2028
        1.4.3 Antimalarial Medication Market Size by Region: 2017 Versus 2021 Versus 2028
2 Antimalarial Medication Market Competition by Manufacturers
    2.1 Global Antimalarial Medication Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Antimalarial Medication Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Antimalarial Medication Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Antimalarial Medication Manufacturing Sites, Area Served, Product Type
    2.5 Antimalarial Medication Market Competitive Situation and Trends
        2.5.1 Antimalarial Medication Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Antimalarial Medication Players Market Share by Revenue
        2.5.3 Global Antimalarial Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antimalarial Medication Retrospective Market Scenario by Region
    3.1 Global Antimalarial Medication Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Antimalarial Medication Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Antimalarial Medication Market Facts & Figures by Country
        3.3.1 North America Antimalarial Medication Sales by Country
        3.3.2 North America Antimalarial Medication Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Antimalarial Medication Market Facts & Figures by Country
        3.4.1 Europe Antimalarial Medication Sales by Country
        3.4.2 Europe Antimalarial Medication Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Antimalarial Medication Market Facts & Figures by Region
        3.5.1 Asia Pacific Antimalarial Medication Sales by Region
        3.5.2 Asia Pacific Antimalarial Medication Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Antimalarial Medication Market Facts & Figures by Country
        3.6.1 Latin America Antimalarial Medication Sales by Country
        3.6.2 Latin America Antimalarial Medication Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Antimalarial Medication Market Facts & Figures by Country
        3.7.1 Middle East and Africa Antimalarial Medication Sales by Country
        3.7.2 Middle East and Africa Antimalarial Medication Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Antimalarial Medication Historic Market Analysis by Type
    4.1 Global Antimalarial Medication Sales Market Share by Type (2017-2022)
    4.2 Global Antimalarial Medication Revenue Market Share by Type (2017-2022)
    4.3 Global Antimalarial Medication Price by Type (2017-2022)
5 Global Antimalarial Medication Historic Market Analysis by Application
    5.1 Global Antimalarial Medication Sales Market Share by Application (2017-2022)
    5.2 Global Antimalarial Medication Revenue Market Share by Application (2017-2022)
    5.3 Global Antimalarial Medication Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 GlaxoSmithKline
        6.1.1 GlaxoSmithKline Corporation Information
        6.1.2 GlaxoSmithKline Description and Business Overview
        6.1.3 GlaxoSmithKline Antimalarial Medication Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 GlaxoSmithKline Antimalarial Medication Product Portfolio
        6.1.5 GlaxoSmithKline Recent Developments/Updates
    6.2 F. Hoffmann-La Roche
        6.2.1 F. Hoffmann-La Roche Corporation Information
        6.2.2 F. Hoffmann-La Roche Description and Business Overview
        6.2.3 F. Hoffmann-La Roche Antimalarial Medication Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 F. Hoffmann-La Roche Antimalarial Medication Product Portfolio
        6.2.5 F. Hoffmann-La Roche Recent Developments/Updates
    6.3 Novartis
        6.3.1 Novartis Corporation Information
        6.3.2 Novartis Description and Business Overview
        6.3.3 Novartis Antimalarial Medication Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Novartis Antimalarial Medication Product Portfolio
        6.3.5 Novartis Recent Developments/Updates
    6.4 Pfizer
        6.4.1 Pfizer Corporation Information
        6.4.2 Pfizer Description and Business Overview
        6.4.3 Pfizer Antimalarial Medication Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Pfizer Antimalarial Medication Product Portfolio
        6.4.5 Pfizer Recent Developments/Updates
    6.5 Sun Pharmaceutical Industries
        6.5.1 Sun Pharmaceutical Industries Corporation Information
        6.5.2 Sun Pharmaceutical Industries Description and Business Overview
        6.5.3 Sun Pharmaceutical Industries Antimalarial Medication Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Sun Pharmaceutical Industries Antimalarial Medication Product Portfolio
        6.5.5 Sun Pharmaceutical Industries Recent Developments/Updates
    6.6 Merck
        6.6.1 Merck Corporation Information
        6.6.2 Merck Description and Business Overview
        6.6.3 Merck Antimalarial Medication Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Merck Antimalarial Medication Product Portfolio
        6.6.5 Merck Recent Developments/Updates
7 Antimalarial Medication Manufacturing Cost Analysis
    7.1 Antimalarial Medication Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Antimalarial Medication
    7.4 Antimalarial Medication Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Antimalarial Medication Distributors List
    8.3 Antimalarial Medication Customers
9 Antimalarial Medication Market Dynamics
    9.1 Antimalarial Medication Industry Trends
    9.2 Antimalarial Medication Market Drivers
    9.3 Antimalarial Medication Market Challenges
    9.4 Antimalarial Medication Market Restraints
10 Global Market Forecast
    10.1 Antimalarial Medication Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Antimalarial Medication by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Antimalarial Medication by Type (2023-2028)
    10.2 Antimalarial Medication Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Antimalarial Medication by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Antimalarial Medication by Application (2023-2028)
    10.3 Antimalarial Medication Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Antimalarial Medication by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Antimalarial Medication by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Antimalarial Medication Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Antimalarial Medication Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Antimalarial Medication Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Antimalarial Medication Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Antimalarial Medication Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Antimalarial Medication Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Antimalarial Medication Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Antimalarial Medication Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Antimalarial Medication Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Antimalarial Medication Manufacturing Sites and Area Served
    Table 11. Manufacturers Antimalarial Medication Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Antimalarial Medication by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antimalarial Medication as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Antimalarial Medication Sales by Region (2017-2022) & (K Units)
    Table 16. Global Antimalarial Medication Sales Market Share by Region (2017-2022)
    Table 17. Global Antimalarial Medication Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Antimalarial Medication Revenue Market Share by Region (2017-2022)
    Table 19. North America Antimalarial Medication Sales by Country (2017-2022) & (K Units)
    Table 20. North America Antimalarial Medication Sales Market Share by Country (2017-2022)
    Table 21. North America Antimalarial Medication Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Antimalarial Medication Revenue Market Share by Country (2017-2022)
    Table 23. Europe Antimalarial Medication Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Antimalarial Medication Sales Market Share by Country (2017-2022)
    Table 25. Europe Antimalarial Medication Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Antimalarial Medication Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Antimalarial Medication Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Antimalarial Medication Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Antimalarial Medication Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Antimalarial Medication Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Antimalarial Medication Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Antimalarial Medication Sales Market Share by Country (2017-2022)
    Table 33. Latin America Antimalarial Medication Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Antimalarial Medication Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Antimalarial Medication Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Antimalarial Medication Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Antimalarial Medication Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Antimalarial Medication Revenue Market Share by Country (2017-2022)
    Table 39. Global Antimalarial Medication Sales by Type (2017-2022) & (K Units)
    Table 40. Global Antimalarial Medication Sales Market Share by Type (2017-2022)
    Table 41. Global Antimalarial Medication Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Antimalarial Medication Revenue Share by Type (2017-2022)
    Table 43. Global Antimalarial Medication Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Antimalarial Medication Sales (K Units) by Application (2017-2022)
    Table 45. Global Antimalarial Medication Sales Market Share by Application (2017-2022)
    Table 46. Global Antimalarial Medication Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Antimalarial Medication Revenue Share by Application (2017-2022)
    Table 48. Global Antimalarial Medication Price by Application (2017-2022) & (USD/Unit)
    Table 49. GlaxoSmithKline Corporation Information
    Table 50. GlaxoSmithKline Description and Business Overview
    Table 51. GlaxoSmithKline Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. GlaxoSmithKline Antimalarial Medication Product
    Table 53. GlaxoSmithKline Recent Developments/Updates
    Table 54. F. Hoffmann-La Roche Corporation Information
    Table 55. F. Hoffmann-La Roche Description and Business Overview
    Table 56. F. Hoffmann-La Roche Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. F. Hoffmann-La Roche Antimalarial Medication Product
    Table 58. F. Hoffmann-La Roche Recent Developments/Updates
    Table 59. Novartis Corporation Information
    Table 60. Novartis Description and Business Overview
    Table 61. Novartis Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Novartis Antimalarial Medication Product
    Table 63. Novartis Recent Developments/Updates
    Table 64. Pfizer Corporation Information
    Table 65. Pfizer Description and Business Overview
    Table 66. Pfizer Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Pfizer Antimalarial Medication Product
    Table 68. Pfizer Recent Developments/Updates
    Table 69. Sun Pharmaceutical Industries Corporation Information
    Table 70. Sun Pharmaceutical Industries Description and Business Overview
    Table 71. Sun Pharmaceutical Industries Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Sun Pharmaceutical Industries Antimalarial Medication Product
    Table 73. Sun Pharmaceutical Industries Recent Developments/Updates
    Table 74. Merck Corporation Information
    Table 75. Merck Description and Business Overview
    Table 76. Merck Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. Merck Antimalarial Medication Product
    Table 78. Merck Recent Developments/Updates
    Table 79. Production Base and Market Concentration Rate of Raw Material
    Table 80. Key Suppliers of Raw Materials
    Table 81. Antimalarial Medication Distributors List
    Table 82. Antimalarial Medication Customers List
    Table 83. Antimalarial Medication Market Trends
    Table 84. Antimalarial Medication Market Drivers
    Table 85. Antimalarial Medication Market Challenges
    Table 86. Antimalarial Medication Market Restraints
    Table 87. Global Antimalarial Medication Sales Forecast by Type (2023-2028) & (K Units)
    Table 88. Global Antimalarial Medication Sales Market Share Forecast by Type (2023-2028)
    Table 89. Global Antimalarial Medication Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 90. Global Antimalarial Medication Revenue Market Share Forecast by Type (2023-2028)
    Table 91. Global Antimalarial Medication Sales Forecast by Application (2023-2028) & (K Units)
    Table 92. Global Antimalarial Medication Sales Market Share Forecast by Application (2023-2028)
    Table 93. Global Antimalarial Medication Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 94. Global Antimalarial Medication Revenue Market Share Forecast by Application (2023-2028)
    Table 95. Global Antimalarial Medication Sales Forecast by Region (2023-2028) & (K Units)
    Table 96. Global Antimalarial Medication Sales Market Share Forecast by Region (2023-2028)
    Table 97. Global Antimalarial Medication Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 98. Global Antimalarial Medication Revenue Market Share Forecast by Region (2023-2028)
    Table 99. Research Programs/Design for This Report
    Table 100. Key Data Information from Secondary Sources
    Table 101. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Antimalarial Medication
    Figure 2. Global Antimalarial Medication Market Share by Type in 2021 & 2028
    Figure 3. Plasmodium Falciparum Product Picture
    Figure 4. Plasmodium Malariae Product Picture
    Figure 5. Plasmodium Vivax Product Picture
    Figure 6. Plasmodium Ovale Product Picture
    Figure 7. Global Antimalarial Medication Market Share by Application in 2021 & 2028
    Figure 8. Hospital Pharmacy
    Figure 9. Retail Pharmacy
    Figure 10. E- Commerce
    Figure 11. Others
    Figure 12. Global Antimalarial Medication Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Antimalarial Medication Market Size (2017-2028) & (US$ Million)
    Figure 14. Global Antimalarial Medication Sales (2017-2028) & (K Units)
    Figure 15. Antimalarial Medication Sales Share by Manufacturers in 2021
    Figure 16. Global Antimalarial Medication Revenue Share by Manufacturers in 2021
    Figure 17. The Global 5 and 10 Largest Antimalarial Medication Players: Market Share by Revenue in 2021
    Figure 18. Antimalarial Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 19. Global Antimalarial Medication Sales Market Share by Region (2017-2022)
    Figure 20. Global Antimalarial Medication Sales Market Share by Region in 2021
    Figure 21. Global Antimalarial Medication Revenue Market Share by Region (2017-2022)
    Figure 22. Global Antimalarial Medication Revenue Market Share by Region in 2021
    Figure 23. U.S. Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Canada Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Germany Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. France Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. U.K. Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Italy Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Russia Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. China Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Japan Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. South Korea Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. India Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Australia Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Taiwan Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Indonesia Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Thailand Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Malaysia Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Philippines Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Vietnam Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Mexico Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Brazil Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Argentina Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Turkey Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Saudi Arabia Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. U.A.E Antimalarial Medication Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Sales Market Share of Antimalarial Medication by Type (2017-2022)
    Figure 48. Manufacturing Cost Structure of Antimalarial Medication
    Figure 49. Manufacturing Process Analysis of Antimalarial Medication
    Figure 50. Antimalarial Medication Industrial Chain Analysis
    Figure 51. Channels of Distribution
    Figure 52. Distributors Profiles
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline
F. Hoffmann-La Roche
Novartis
Pfizer
Sun Pharmaceutical Industries
Merck
Frequently Asked Questions
Antimalarial Medication report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Antimalarial Medication report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Antimalarial Medication report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports